MGMT and glioblastoma: Whether the sequentially applied combination of TMZ+AT101/AT101 is efficient in GBM cells with unmethylated MGMT promoters and which chemoresistance mechanisms might be developed by GBM cells upon the therapy can be the focus of follow-up studies.